Neurochemistry pp 1029-1034 | Cite as
CMP-Dependent Degradation of Platelet-Activating Factor (PAF) by Rat Brain Microsomes
Abstract
PAF (l-O-alkyl-2-acetyl-5-sn-glycero-3-phosphocholine) is a potent lipid mediator that, in the nervous tissue, participates to physiological phenomena as well as in those related to pathological events (1,2). For instance, PAF is involved in neurotransmission (3–6) and it has been recently proposed as a retrograde messenger in hippocampal longterm potentiation (7,8) and in memory formation (9). On the other hand, it has been also reported that PAF concentration increases during cerebral ischemia and convulsions (10,11) and that PAF antagonists reduce brain damage associated with these pathological conditions (12,13). Thus, it is of great importance to know of the mechanisms controlling the concentration of this lipid mediator in the nervous tissue and consequently the regulation of the enzymes involved in its synthesis and degradation.
Keywords
Nervous Tissue Ehrlich Ascites Cell Retrograde Messenger Remodel Pathway Phosphocholine CytidylyltransferasePreview
Unable to display preview. Download preview PDF.
References
- 1.Goracci, G., 1990, Pharmacology of cerebral ischemia, (Krieglstein, J. and Oberpichler, H., Eds.), Wissenschaftliche Verlagsgesellshaft, Stuttgart, pp. 377–390.Google Scholar
- 2.Baker, R.R., 1995, Neurochem. Res. 20: 1345–1351.PubMedCrossRefGoogle Scholar
- 3.Bussolino, F., Gremo, F., Tetta, C., Pescarmona, G.P., and Camussi, G., 1986, J. Biol. Chem. 261: 16502–16508.PubMedGoogle Scholar
- 4.Bussolino, F., Pescarmona, G., Camussi, G. and Gremo, F., 1988, J. Neurochem. 51: 1755–1759.PubMedCrossRefGoogle Scholar
- 5.Bussolino, F., Tessari, F., Turrini, F., Braquet, P., Camussi, G., Prosdocimi, M., and Bosia, A., 1988, Am. J. Physiol. 255 (Cell physiol) 24, 1755–1759.Google Scholar
- 6.Clark, G.D., Happel, L.T., Zorumski, CF. and Bazan, N.G., 1992, Neuron 9: 1211–1216PubMedCrossRefGoogle Scholar
- 7.Wierasko, A., Li, G., Komecki, E., Hogan, M.V., and Ehrlich, Y.H., 1993, Neuron 10: 553–557.CrossRefGoogle Scholar
- 8.Kato, K., Clark, G.D., Bazan, N.G., and Zorumski, CF., 1994, Nature 367: 173–179.CrossRefGoogle Scholar
- 9.Izquerdo, I., Fin, C., Schmitz, P.K., Da Silva, R.C., Jerusalinsky, D., Quillfeldt, J.A., Ferreira, M.B.G., Medina, J.H., and Bazan, N.G., 1995, Proc. Natl. Acad. Sci. USA 92: 5047–5051.CrossRefGoogle Scholar
- 10.Kumar, R., Harvey, S.A.K., Kester, M., Hanahan, D.J., and Olson, M.S., 1988, Biochim. Biophys. Acta 963: 375–383.PubMedCrossRefGoogle Scholar
- 11.Domingo, M.T., Spinnewyn, P., Chabrier, E., and Braquet, P., 1994, Brain Res. 640: 268–276PubMedCrossRefGoogle Scholar
- 12.Birkle, D.L., Kurian, P., Braquet, P., and Bazan, N.G., 1988, J.Neurochem. 51: 1900–1905.PubMedCrossRefGoogle Scholar
- 13.Panetta, T., Marcheselli, V.L., Braquet, P., Spinnewyn, B., and Bazan, N.G., 1987, Biochem. Biophys. Res. Commun. 149: 580–587.PubMedCrossRefGoogle Scholar
- 14.Francescangeli, E. and Goracci, G., 1989, Biochem. Biophys. Res. Commun. 161: 107–112.PubMedCrossRefGoogle Scholar
- 15.Baker, R.R., and Chang, H-Y, 1994, Biochim. Biophys. Acta 1213: 27–33.PubMedCrossRefGoogle Scholar
- 16.Baker, R.R., and Chang, H-Y., 1995, J. Neurochem. 64: 364–370.PubMedCrossRefGoogle Scholar
- 17.Blank, M.L., Lee, Y.J., Cress, E.A., and Snyder, F., 1988, J.Biol.Chem. 263: 5456–5661.Google Scholar
- 18.Goracci, G., and Francescangeli, E., 1995, J. Neurochem. 64S: 37D.Google Scholar
- 19.Snyder, F., 1995, Biochem. J. 305: 689–705.PubMedGoogle Scholar
- 20.Woelk, H., Goracci, G., and Porcellati, G., 1974, Hoppe-Seyler’s Z. Physiol. Chem. 355: 75–81.CrossRefGoogle Scholar
- 21.Blank, M.L., Smith, Z.L., Fitzgerald, V, and Snyder, F., 1995, Biochim. Biophys. Acta 1254: 295–301.PubMedCrossRefGoogle Scholar
- 22.Goracci, G., and Francescangeli, E., 1991, Lipids 26: 986–991.PubMedCrossRefGoogle Scholar
- 23.Hattori, M., Arai, H. and Inoue, K., 1993, J. Biol. Chem. 268: 18748–18753.PubMedGoogle Scholar
- 24.Wikle, R.L., and Schremmer, J.M., 1974, J.Biol.Chem. 249: 1742–1746.Google Scholar
- 25.Goracci, G., Francescangeli, E., Horrocks, L.A., and Porcellati, G., 1981, Biochim.Biophys. Acta 664: 373–379PubMedCrossRefGoogle Scholar
- 26.Goracci, G., Francescangeli, E., Horrocks, L.A., and Porcellati, G., 1986, Biochim. Biophys. Acta 876: 387–391.PubMedCrossRefGoogle Scholar
- 27.Goracci, G., Francescangeli, E., Horrocks, L.A., and Porcellati, G., 1983, Neurochem. Res. 8: 971–981.PubMedCrossRefGoogle Scholar
- 28.Goracci, G., Francescangeli, E., Floridi, A., Horrocks, L.A., and Porcellati, G., 1985, Phospholipid in the nervous system: vol.2; Physiological roles (Horrocks, L.A., Kanfer, J.N., and Porcellati, G., eds.), Raven Press, New York, PP 121–129.Google Scholar
- 29.Bligh, E.G., and Dyer, W., 1959, Can. J. Biochem. Physiol. 37: 911–917.PubMedCrossRefGoogle Scholar
- 30.Lowry, O.H., Rosebrough, N.J., Fair, A.L., and Randall, P.J., 1951 J.Biol. Chem. 193: 265–275.PubMedGoogle Scholar
- 31.Blank, M.L., Smith, Z.L., Cress, E.A., and Snyder, F., 1990, Biochim.Biophys. Acta 1042: 153–158.PubMedCrossRefGoogle Scholar
- 32.Farooqui, A.A., Hirashima, Y, Farooqui, T. and Horrocks, L.A., 1992, Neurochemical correlates of cerebral ischemia, (Bazan, N.G., Braquet, P., and Ginsberg, M.D., eds) Plenum Press, New York, PP 117–138.Google Scholar
- 33.Francescangeli, E., Domanka-Janik, K., and Goracci, G., 1996, J. Lipid Med. in pressGoogle Scholar
- 34.Rordorf, G., Uemura, Y, and Bonventre, J.V., 1991 J.Neurose. 11: 1829–1836.Google Scholar
- 35.Domanska-Janik, K. and Zalewska, T., 1992, J. Neurochem. 58: 1432–1439.PubMedCrossRefGoogle Scholar
- 36.Domanska-Janik, K., and Zabloka, B., 1993, Chem. Neuropathol. 20: 111–123.CrossRefGoogle Scholar